- Home
- GENI vs AAPG Comparison
GENI vs AAPG Comparison
Compare GENI & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GENI
- AAPG
- Stock Information
- Founded
- GENI 2016
- AAPG 2009
- Country
- GENI United Kingdom
- AAPG China
- Employees
- GENI N/A
- AAPG N/A
- Industry
- GENI Services-Misc. Amusement & Recreation
- AAPG Biotechnology: Pharmaceutical Preparations
- Sector
- GENI Consumer Discretionary
- AAPG Health Care
- Exchange
- GENI Nasdaq
- AAPG Nasdaq
- Market Cap
- GENI 3.0B
- AAPG 3.6B
- IPO Year
- GENI N/A
- AAPG 2025
- Fundamental
- Price
- GENI $11.01
- AAPG $32.91
- Analyst Decision
- GENI Strong Buy
- AAPG Buy
- Analyst Count
- GENI 17
- AAPG 2
- Target Price
- GENI $13.88
- AAPG $48.00
- AVG Volume (30 Days)
- GENI 5.1M
- AAPG 8.4K
- Earning Date
- GENI 11-04-2025
- AAPG 11-19-2025
- Dividend Yield
- GENI N/A
- AAPG N/A
- EPS Growth
- GENI N/A
- AAPG N/A
- EPS
- GENI N/A
- AAPG N/A
- Revenue
- GENI $604,524,000.00
- AAPG $54,524,554.00
- Revenue This Year
- GENI $28.54
- AAPG N/A
- Revenue Next Year
- GENI $17.14
- AAPG $368.64
- P/E Ratio
- GENI N/A
- AAPG N/A
- Revenue Growth
- GENI 30.70
- AAPG N/A
- 52 Week Low
- GENI $6.72
- AAPG $16.50
- 52 Week High
- GENI $13.73
- AAPG $48.45
- Technical
- Relative Strength Index (RSI)
- GENI 35.28
- AAPG 37.33
- Support Level
- GENI $10.52
- AAPG $32.68
- Resistance Level
- GENI $11.52
- AAPG $34.31
- Average True Range (ATR)
- GENI 0.43
- AAPG 0.76
- MACD
- GENI -0.07
- AAPG 0.01
- Stochastic Oscillator
- GENI 29.79
- AAPG 7.23
About GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.